IRADIMED Sees Q4 FY23 Revenue Of $16.9M-$17.4M Versus Consensus Of $17.01M
Portfolio Pulse from Benzinga Newsdesk
IRADIMED has projected its Q4 FY23 revenue to be between $16.9M and $17.4M, which is in line with the consensus estimate of $17.01M.
November 03, 2023 | 12:04 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
IRADIMED's Q4 FY23 revenue projection is in line with market expectations, which could maintain investor confidence.
IRADIMED's revenue forecast for Q4 FY23 is in line with the consensus estimate. This suggests that the company's performance is as expected, which could maintain investor confidence and have a neutral impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100